TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

International Journal of Advances In Case Reports

Volume 11, Issue 1, 2024
Mcmed International
International Journal of Advances In Case Reports
Issn
XXX-XXXX (Print), 2349 - 8005 (Online)
Frequency
bi-annual
Email
editorijacr@mcmed.us
Journal Home page
http://mcmed.us/about/ijacr
Recommend to
A Friend  | A librarian
Purchase
Purchase Issue
Abstract
Title
SIDE EFFECTS OF THE OPHTHALMIC CYCLOPENTOLATE IN ADULT
Author
Banu Karakus Yilmaz, Kubra Sereflioglu Cabuk, Erdem Cevik*, Yasemin Celik, Ozlem Uzun, Hatice Topcu
Email
cevikerdem@yahoo.com
keyword
Cyclopentolate, Side effects, Disequilibrium.
Abstract
Cyclopentolate adverse affects are rare and dose-dependent. We report the occurrence of a significant systemic reaction to 1% cyclopentolate eye drops in a normal dosage manifesting as inability to walk, disequilibrium, dysarthria, and impaired cognition. A 78 year-old woman presented the emergency department with inability to walk, disequilibrium, dysarthria, and disorientation 5 minutes after 4 drips of eye drops containing 1% cyclopentolate were placed in both eyes for evaluation of the retina in routine eye examination. She was conscious and had no prior history of convulsions. His vital signs were normal. In eye examination, pupils were mydriatic, and there was no pupil reflex. Evidence relative to atropinization was not determined in systemic examination. Serum glucose levels, blood count, biochemical parameters, and blood gas analyses were within reference ranges. Intracranial pathologic findings were not determined in computed cranial tomography and diffusion weighed MR. His clinical symptoms deteriorated at 4-hour follow-up, and he was discharged without any complaint at 12hours. These clinical findings were dedicated to adverse affect of cyclopentolate because of no convulsion history in the patient and his family. Delirium and extra pyramidal side effects are well known adverse affects of cyclopentolate and especially occur with oral and parenteral use. Adult patient can present with similar findings after use of local cyclopentolate. Doctors should remember these adverse affects and treated these patients.
Download Broucher
Back to Top >>>>